Sublingual protein delivery by a mucoadhesive patch made of natural polymers
Source abstract
Abstract
The sublingual mucosa is an appealing route for drug administration. However, in the context of increased use of therapeutic proteins, development of protein delivery systems that will protect the protein bioactivity is needed. As proteins are fragile and complex molecules, current sublingual formulations of proteins are in liquid dosage. Yet, protein dilution and short residence time at the sublingual mucosa are the main barriers for the control of the dose that is delivered. In this work, a simple delivery scaffold based on the assembly of two polysaccharides, chitosan and hyaluronic acid, is presented. The natural polymers were assembled by the Layer-by-Layer methodology to produce a mucoadhesive and oro-dispersible freestanding membrane, shown to be innocuous for epithelial human cells. The functionalization of the membrane with proteins led to the production of a bioactive patch with efficient loading and release of proteins, and suitable mechanical properties for manipulation. Sublingual administration of the patch in mouse evidenced the absence of inflammation and an extended time of contact between the model protein ovalbumin and the mucosa compared to liquid formulation. The delivery of fluorescent ovalbumin in mouse sublingual mucosa demonstrated the penetration of the protein in the epithelium 10 min after the patch administration. Moreover, a migration assay with a chemokine incorporated into the patch showed no decrease in bioactivity of the loaded protein after enzymatic release. This study therefore provides a promising strategy to develop a sublingual protein delivery system. STATEMENT OF SIGNIFICANCE: Although the oral route is largely used for drug delivery, it has limitations for the delivery of proteins that can be degraded by pH or gastric enzymes. The sublingual route therefore appears as an interesting approach for protein administration. In this work, a simple delivery scaffold is presented based on the assembly of two polysaccharides by the Layer-by-Layer methodology to produce a mucoadhesive patch. The produced patch allowed efficient loading and release of proteins, as well as protection of their bioactivity. An extended time of contact between the protein and the mucosa compared to liquid formulation was highlighted in mouse model. This study provides a promising strategy to develop a sublingual protein delivery system.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Polymer Surface Interaction Studies · Oral and gingival health research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Buccal bioadhesive drug delivery - A promising option for orally less efficient drugs10.1016/j.jconrel.2006.04.012 ↗
2. Enhancing the buccal mucosal delivery of peptide and protein therapeutics10.1007/s11095-014-1485-1 ↗
3. Non-invasive systemic drug delivery through mucosal routes, Artif. Cells
4. Insulin Buccal Spray (Oral-Lyn) efficacy in Type 1 Diabetes
5. HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge
6. Enhancing allergen-presentation platforms for sublingual immunotherapy10.1016/j.jaip.2016.07.020 ↗
7. Buccal and sublingual vaccine delivery10.1016/j.jconrel.2014.05.060 ↗
8. Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy products10.1371/journal.pone.0183398 ↗
9. Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines10.1016/j.jconrel.2014.03.018 ↗
10. Preparing an adjuvanted thermoresponsive gel formulation for sublingual vaccination10.1007/978-1-4939-6445-1_11 ↗
11. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines10.1016/j.jconrel.2016.07.036 ↗
12. Advances in oral transmucosal drug delivery10.1016/j.jconrel.2011.01.027 ↗
13. Drug delivery techniques for buccal route: formulation strategies and recent advances in dosage form design10.1007/s40005-016-0281-9 ↗
14. The power of saliva: antimicrobial and beyond10.1371/journal.ppat.1008058 ↗
15. The use of mucoadhesive polymers in buccal drug delivery10.1016/j.addr.2005.07.003 ↗
16. Buccal drug delivery10.1517/17425247.2.3.507 ↗
17. 5-Methyl-pyrrolidinone chitosan films as carriers for buccal administration of proteins10.1208/pt070370 ↗
18. Preparation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin10.1002/jbm.a.32071 ↗
19. Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction10.1111/j.1398-9995.2009.01945.x ↗
20. Development and physico-mechanical characterisation of lyophilised chitosan wafers as potential protein drug delivery systems via the buccal mucosa10.1016/j.colsurfb.2011.11.004 ↗
21. Chitosan and its salts for mucosal and transmucosal delivery10.1517/17425240903114142 ↗
22. Why Chitosan? From properties to perspective of mucosal drug delivery10.1016/j.ijbiomac.2016.05.054 ↗
23. Fuzzy nanoassemblies: toward layered polymeric multicomposites10.1126/science.277.5330.1232 ↗
24. Myoconductive and osteoinductive free-standing polysaccharide membranes10.1016/j.actbio.2014.12.027 ↗
25. Chemotherapy induces oral mucositis in mice without additional noxious stimuli10.1016/j.tranon.2017.05.001 ↗
26. Artificial saliva and its use in biological experiments
27. M.A. Pogrel, M.A. Low, R. Stern, Hyaluronan and its regulation in human saliva by hyaluronidase and its inhibitors, 45 (2003) 85–91.10.2334/josnusd.45.85 ↗
28. Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8 + T cell crosspriming in vivo10.1016/j.immuni.2006.01.005 ↗
29. Molecular basis for the explanation of the exponential growth of polyelectrolyte multilayers10.1073/pnas.202486099 ↗
30. Molecular interactions driving the layer-by-layer assembly of multilayers10.1021/cr400531v ↗
31. Enzymatic degradation of polysaccharide-based layer-by-layer structures10.1021/acs.biomac.5b01742 ↗
32. Site-specific regulation of oral mucosa-recruiting CD8+T cells in a mouse contact allergy model10.1016/j.bbrc.2017.07.012 ↗
33. Epidermal cytokines in murine cutaneous irritant responses10.1002/1099-1263(200007/08)20:4<335::AID-JAT698>3.0.CO;2-L ↗
34. Degradability of polysaccharides multilayer films in the oral environment: an in vitro and in vivo study10.1021/bm049425u ↗
35. Optimization of two biopolymer-based oral films for the delivery of bioactive molecules10.1016/j.msec.2017.02.173 ↗
36. Dynamic mechanical analysis in polymers for medical applications
37. Evaluation of the clearance characteristics of bioadhesive systems in humans10.1016/S0378-5173(98)00367-6 ↗
38. Why is chitosan mucoadhesive?10.1021/bm800276d ↗
39. Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP10.1371/journal.pone.0026973 ↗
40. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses10.1016/j.vaccine.2013.12.043 ↗
41. Sublingual immunization with an HIV subunit vaccine induces antibodies and cytotoxic T cells in the mouse female genital tract10.1016/j.vaccine.2010.06.033 ↗
42. Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example10.1016/j.carres.2008.01.047 ↗
43. Tuning the hydrophilic/hydrophobic balance to control the structure of chitosan films and their protein release behavior10.1208/s12249-016-0678-9 ↗
44. Secondary structure of rhBMP-2 in a protective biopolymeric carrier material10.1021/bm3010808 ↗
45. The stability of BMP loaded polyelectrolyte multilayer coatings on titanium10.1016/j.biomaterials.2013.03.067 ↗